Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Howard

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Transplantation and Cellular Therapy|July 12, 2023
Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell TransplantationAbel Santos Carreira, Maria Queralt Salas, Mats Remberger, et al.
European Journal of Haematology|February 2, 2023
Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysisRam Vasudevan Nampoothiri, Kenny Tang, Andre Schuh, et al.
Bone Marrow Transplantation|December 16, 2022
Impact of hematopoietic cell transplant frailty scale on transplant outcome in adultsMaria Queralt Salas, Eshetu G Atenafu, Ivan Pasic, et al.
JACC. Advances|May 23, 2025
Early Cardiovascular Events in Recipients of Allogeneic Hematopoietic Stem Cell TransplantationNazanin Aghel, Vincent Wang, Darryl Leong, et al.
Bone Marrow Transplantation|August 24, 2023
HCT frailty scale for younger and older adults undergoing allogeneic hematopoietic cell transplantationMaria Queralt Salas, Eshetu G Atenafu, Ivan Pasic, et al.
Research Square|March 30, 2023
Refining the serum miR-371a-3p test for viable germ cell tumor detection: identification and definition of an indeterminate rangeJohn Lafin, Cinzia Scarpini, Armon Amini, et al.
Annals of Internal Medicine|February 21, 2018
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label StudyFrançois-Xavier Mahon, Carla Boquimpani, Dong-Wook Kim, et al.
European Urology Focus|February 8, 2025
Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing TherapiesDrupad Annapureddy, Jacob I Taylor, Ashish M Kamat, et al.
BJU International|August 26, 2024
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancerJacob I Taylor, Ashish M Kamat, Michael A O'Donnell, et al.
European Urology Oncology|December 18, 2024
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle Invasive Bladder CancerJacob Taylor, Ashish M Kamat, Drupad Annapureddy, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Transplantation and Cellular Therapy|July 12, 2023
Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell TransplantationAbel Santos Carreira, Maria Queralt Salas, Mats Remberger, et al.
European Journal of Haematology|February 2, 2023
Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysisRam Vasudevan Nampoothiri, Kenny Tang, Andre Schuh, et al.
Bone Marrow Transplantation|December 16, 2022
Impact of hematopoietic cell transplant frailty scale on transplant outcome in adultsMaria Queralt Salas, Eshetu G Atenafu, Ivan Pasic, et al.
JACC. Advances|May 23, 2025
Early Cardiovascular Events in Recipients of Allogeneic Hematopoietic Stem Cell TransplantationNazanin Aghel, Vincent Wang, Darryl Leong, et al.
Bone Marrow Transplantation|August 24, 2023
HCT frailty scale for younger and older adults undergoing allogeneic hematopoietic cell transplantationMaria Queralt Salas, Eshetu G Atenafu, Ivan Pasic, et al.
Research Square|March 30, 2023
Refining the serum miR-371a-3p test for viable germ cell tumor detection: identification and definition of an indeterminate rangeJohn Lafin, Cinzia Scarpini, Armon Amini, et al.
Annals of Internal Medicine|February 21, 2018
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label StudyFrançois-Xavier Mahon, Carla Boquimpani, Dong-Wook Kim, et al.
European Urology Focus|February 8, 2025
Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing TherapiesDrupad Annapureddy, Jacob I Taylor, Ashish M Kamat, et al.
BJU International|August 26, 2024
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancerJacob I Taylor, Ashish M Kamat, Michael A O'Donnell, et al.
European Urology Oncology|December 18, 2024
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle Invasive Bladder CancerJacob Taylor, Ashish M Kamat, Drupad Annapureddy, et al.
Pageof 7